Potential Benefits of Probiotics in Obese COVID-19 Patients
Over the past couple of months amidst an aggressive second wave, the coronavirus disease-19 (COVID-19) pandemic has continued to emerge as an enormous burden on national public health resources, affecting and threatening even the middle-aged population this time.(1)
It has been observed that overweight or obese population are at an independent risk for development of upper and lower respiratory tract infections and delayed recovery through it.(2) Along the same lines, it is reported that obese patients carry a higher risk of contracting COVID-19 infections and developing more severe disease, including increased mortality.(3) The evidence supporting the use of probiotics in this patient population is reviewed and summarised with clinical relevance.
1. Sundararaman A, Ray M, Ravindra PV, Halami PM. Role of probiotics to combat viral infections with emphasis on COVID-19 [published online ahead of print, 2020 Aug 19]. Appl Microbiol Biotechnol. 2020;1-16. doi:10.1007/s00253-020-10832-4
Prof. Dr. T. P. Kalaniti is the Director - Medical Education, KMCH Institute of Health Sciences and Research, Coimbatore